AccuVein signs five-year agreement with the Ferrer Group

Download PDF Copy

Oct 19 2009

AccuVein LLC today announced a five-year agreement with the Ferrer Group, a leading international pharmaceutical and medical devices distribution company, providing the AccuVein AV300, the world's first hand-held, non-contact vein illumination device, to customers in Greece, Spain and Portugal. The AccuVein AV300 helps healthcare professionals locate veins for blood draw, IV infusion and blood donation by projecting a pattern of light on a patient's skin that reveals vein position.

"Ferrer Group's broad customer base share a common desire - to use advanced medical technology products that add value to reducing costs and improving patient care," said Jose Luis Lirio, Ferrer Group. "We're pleased to bring the world's only portable vein illumination device into our distribution."

"This agreement significantly expands the AV300's global availability into these important markets," said Stephen P. Conlon, President of AccuVein. "Healthcare practitioners in Greece, Spain and Portugal now have access to the device to reduce time and effort in accessing veins."

SOURCE AccuVein LLC

Posted in:

Comments (0)

Download PDF Copy

Suggested Reading

Metformin’s blood sugar control starts in the brain, not just the liver, study finds

Can ginger help diabetes? Major review says yes, it lowers blood sugar and inflammation effectively

Duke-NUS sharpens focus on population health and technology-enabled research

Why Spirulina could be a helpful natural option for lowering blood pressure

Epigenetic breakthrough: $200 blood test spots diabetes heart risk better than standard tools

Beetroot juice lowers blood pressure in older adults by reshaping oral bacteria

Two-step blood and scan strategy delivers near-perfect accuracy for early Alzheimer's signs

AI rollout in NHS hospitals faces major challenges

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.

Post a new comment

(Logout)

Post

Sign in to keep reading

We're committed to providing free access to quality science. By registering and providing insight into your preferences you're joining a community of over 1m science interested individuals and help us to provide you with insightful content whilst keeping our service free.